İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2021 · article

The Outcome of COVID‐19 in Patients with Hematological Malignancy

ISSN0146-6615
YÖKSİS OpenAlex Açık erişim · bronze Üst %10
Yıl2021
Atıf134OpenAlex
Atıf120Semantic Scholar · 7 etkili
Yüzdelik%98,4
FWCI8,581,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q1

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıJournal of medical virology
  • Katalog eşleşmesi (ISSN)Journal of Medical Virology
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

In this study, we aim to report the outcomes for COVID-19 in patients with hematological malignancy in Turkey. Data from laboratory-confirmed 188 897 COVID-19 patients diagnosed between 11 March 2020 and 22 June 2020 included in the Republic of Turkey, Ministry of Health database were analyzed retrospectively. All COVID-19 patients with hematological malignancy (n = 740) were included in the study and an age, sex, and comorbidity-matched cohort of COVID-19 patients without cancer (n = 740) at a 1:1 ratio was used for comparison. Non-Hodgkin lymphoma (30.1%), myelodysplastic syndrome (19.7%), myeloproliferative neoplasm (15.7%) were the most common hematological malignancies. The rates of severe and critical disease were significantly higher in patients with hematological malignancy compared with patients without cancer (P = .001). The rates of hospital and intensive care unit (ICU) admission were higher in patients with hematological malignancy compared with the patients without cancer (P = .023, P = .001, respectively). The length of hospital stay and ICU stay was similar between groups (P = .7, P = .3, retrospectively). The rate of mechanical ventilation (MV) support was higher in patients with hematological malignancy compared with the control group (P = .001). The case fatality rate was 13.8% in patients with hematological malignancy, and it was 6.8% in the control group (P = .001). This study reveals that there is an increased risk of COVID-19-related serious events (ICU admission, MV support, or death) in patients with hematological malignancy compared with COVID-19 patients without cancer and confirms the high vulnerability of patients with hematological malignancy in the current pandemic.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

134atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 85 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2021 COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)Atıf 321 · OpenAlex
  2. 2021 COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)Atıf 321 · OpenAlex
  3. 2021 COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)Atıf 321 · OpenAlex
  4. 2020 The outcome of COVID‐19 in patients with hematological malignancyAtıf 134 · OpenAlex
  5. 2021 Convalescent plasma therapy in patients with COVID-19Atıf 65 · OpenAlex
  6. 2021 Convalescent plasma therapy in patients with COVID-19Atıf 65 · OpenAlex
  7. 2021 Convalescent plasma therapy in patients with COVID-19Atıf 65 · OpenAlex
  8. 2020 Convalescent plasma therapy in patients with COVID-19Atıf 65 · OpenAlex
  9. 2021 Convalescent plasma therapy in patients with COVID-19Atıf 37 · OpenAlex
  10. 2021 COVID-19 in hematopoietic cell transplant recipientsAtıf 31 · OpenAlex

Yazarlar

18
  1. TUĞÇE NUR YİĞENOĞLU 1
  2. NAİM ATA 2
  3. FEVZİ ALTUNTAŞ 3
  4. SEMİH BAŞCI DOKUZ EYLÜL ÜNİVERSİTESİ 4
  5. MEHMET SİNAN DAL SAĞLIK BİLİMLERİ ÜNİVERSİTESİ 5
  6. SERDAL KORKMAZ 6
  7. SİNEM NAMDAROĞLU DOKUZ EYLÜL ÜNİVERSİTESİ 7
  8. ABDULKADİR BAŞTÜRK SAĞLIK BİLİMLERİ ÜNİVERSİTESİ 8
  9. TUBA HACIBEKİROĞLU SAKARYA ÜNİVERSİTESİ 9
  10. MEHMET HİLMİ DOĞU İSTİNYE ÜNİVERSİTESİ 10
  11. İLHAMİ BERBER İNÖNÜ ÜNİVERSİTESİ 11
  12. KÜRŞAT DAL 12
  13. MEHMET ALİ ERKURT 13
  14. BURHAN TURGUT ALTINBAŞ ÜNİVERSİTESİ 14
  15. MUSTAFA MAHİR ÜLGÜ 15
  16. OSMAN ÇELİK 16
  17. ERSAN İMRAT 17
  18. ŞUAYİP BİRİNCİ 18